New triple inhaler aims to tame uncontrolled asthma
NCT ID NCT07546981
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tests whether a new inhaler with three medicines (CHF 5993) works better than a standard two-medicine inhaler for people whose asthma is not well controlled. About 554 Chinese adults with asthma will use either the triple or dual inhaler for 24 weeks. The main goal is to see if the triple inhaler improves lung function more.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Friendship Hospital
Beijing, Chaoyang District, China
-
China-Japan Friendship Hospital
Beijing, Chaoyang District, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.